Further, our findings raise hypotheses that warrant further testing to improve our understanding of the potential role of lipid handling impairment in the setting of PPT1 deficiency and in the pathobiology of INCL. The gene discussed is PPT1; the disease is infantile neuronal ceroid lipofuscinosis.